Reduced exercise capacity in genetic haemochromatosis

European Journal of Preventive Cardiology

Volumn 14, Issue 3, 2007, Pages 470-475

  Davidsen, Einar Skulstad ^a   Liseth, Knut ^a   Omvik, Per ^b   Hervig, Tor ^a   Gerdts, Eva ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

echocardiography; exercise test; haemochromatosis; oxygen consumption; spirometry

Indexed keywords

FERRITIN;

ADULT; ARTICLE; BLOOD DONOR; BODY HEIGHT; BODY WEIGHT; BREATHING; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; COVARIANCE; CYCLING; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; GAS EXCHANGE; GENETIC DISORDER; GENOTYPE; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEMOCHROMATOSIS; HUMAN; ISOVOLUMIC RELAXATION TIME; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MUSCLE TRAINING; OBESITY; OXYGEN CONSUMPTION; PHLEBOTOMY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REST; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; CASE-CONTROL STUDIES; EXERCISE TOLERANCE; FEMALE; HEART VENTRICLES; HEMOCHROMATOSIS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MUSCLE FATIGUE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PHLEBOTOMY; RESEARCH DESIGN; VENTRICULAR FUNCTION;

EID: 34250654881     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3280ac151c     Document Type: Article

References (19)

1. Dabestani A, Child JS, Perloff JK, Figueroa WG, Schelbert HR, Engel TR, Cardiac abnormalities in primary hemochromatosis. Ann N Y Acad Sci 1988; 526: 234–244.
2. Adams P, Brissot P, Powell LW, EASL international consensus conference on haemochromatosis. J Hepatol 2000; 33: 485–504.
3. A'Rsberg A, Hveem K, Thorstensen K, Ellekjær E, Kannelønning K, Fjøsne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65 238 persons. Scand J Gastroenterol 2001; 36: 1108–1115.
4. Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med 2004; 350: 2383–2397.
5. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ, Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275–278.
6. A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK haemochromatosis consortium. Gut 1997; 41: 841–844.
7. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79–108.
8. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
9. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB, Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 1996; 28: 751–756.
10. Ilercil A, O'Grady MJ, Roman MJ, Paranicas M, Lee ET, Welty TK, et al. Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the strong heart study. J Am Soc Echocardiogr 2001; 14: 601–611.
11. Wahr DW, Wang YS, Schiller NB, Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population. J Am Coll Cardiol 1983; 1: 863–868.
12. Appleton CP, Jensen JL, Hatle LK, Oh JK, Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. J Am Soc Echocardiogr 1997; 10: 271–292.
13. Gerdts E, Bjornstad H, Toft S, Devereux RB, Omvik P. Impact of diastolic Doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). J Hypertens 2002; 20: 1223–1229.
14. Missault L, Duprez D, de Buyzere M, de Backer G, Clement D. Decreased exercise capacity in mild essential hypertension: non-invasive indicators of limiting factors. J Hum Hypertens 1992; 6: 151–155.
15. Ogawa T, Spina RJ, Martin WH III, Kohrt WM, Schechtman KB, Holloszy JO, et al. Effects of aging, sex, and physical training on cardiovascular responses to exercise. Circulation 1992; 86: 494–503.
16. Olson LJ, Edwards WD, Holmes DR Jr, Miller FA Jr, Nordstrom LA, Baldus WP, Endomyocardial biopsy in hemochromatosis: clinicopathologic correlates in six cases. J Am Coll Cardiol 1989; 13: 116–120.
17. Candell-Riera J, Lu L, Seres L, Gonzalez JB, Batlle J, Permanyer-Miralda G, et al. Cardiac hemochromatosis: beneficial effects of iron removal therapy. An echocardiographic study. Am J Cardiol 1983; 52: 824–829.
18. Mahon NG, Coonar AS, Jeffery S, Coccolo F, Akiyu J, Zal B, et al. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart 2000; 84: 541–547.
19. Omvik P, Lund-Johansen P. Hemodynamic response to exercise in hypertension and its modulation by anti-hypertensive therapy. In: Safar ME, Fouad-Tarazi FM, editors. The heart in hypertension. Dordrecht: Kluwer Academic Publishers; 1989. pp. 370–394.